Artrya Company Description

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.

The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack.

Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Artrya Limited

Country	Australia
Founded	2018
Industry	Health Information Services
Sector	Healthcare
CEO	John Konstantopoulos

Contact Details

Address: 1257 Hay Street West Perth, 6005 Australia
Phone	61 8 6478 7816
Website	artrya.com

Stock Details

Ticker Symbol	AYA
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU0000182412
SIC Code	7372

Key Executives

Name	Position
John Konstantopoulos B.E.	Co-Founder and Chief Executive Officer
Bernard William Ridgeway F.A.C.I.D.	Executive Chair
Harvey Farrington	Acting Chief Financial Officer
Phil Bowen	Chief Operations Officer
Prof. Girish Dwivedi M.D.	Chief Scientific Officer
Dr. Richard M. Stewart	Chief Regulatory Affairs and Quality Officer
Ryan Athearn	Head of Global Clinical Operations
Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A.	Company Secretary